Please login to the form below

Not currently logged in


This page shows the latest Oligomannate news and features for those working in and with pharma, biotech and healthcare.

China okays Green Valley’s algae-based drug for Alzheimer’s drug

China okays Green Valley’s algae-based drug for Alzheimer’s drug

Oligomannate is the first new drug to be approved for  Alzheimer’s since memantine, which was approved in Europe in 2002 and the US in 2003. ... Green Valley says it will launch Oligomannate in China 'very soon' while also carrying out trials to

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (, a trusted independent medical website. Support the...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....